High-throughput screening applied to drug synthesis process development.

Area of Science:

• Pharmaceutical Chemistry
• Process Development
• Drug Discovery

Background:

• Combinatorial chemistry and high-throughput screening (HTS) have significantly accelerated the identification of potential drug molecules.
• The rapid increase in compound libraries has led to a bottleneck in developing efficient and scalable manufacturing processes for these drug candidates.
• Existing chemical process development methods struggle to keep pace with the accelerated discovery phase.

Purpose of the Study:

• To review developments in implementing high-throughput screening (HTS) specifically for chemical process development.
• To address the bottleneck in scaling up the manufacture of newly discovered drug candidates.
• To highlight strategies for improving productivity in pharmaceutical chemical development.

Main Methods:

• Review of current literature and industry practices regarding HTS in process chemistry.
• Analysis of adaptations of HTS technologies for chemical synthesis and optimization.
• Examination of case studies demonstrating the application of HTS in pharmaceutical manufacturing.

Main Results:

• High-throughput screening is being adapted and implemented within pharmaceutical chemical development groups and their suppliers.
• These adapted HTS approaches aim to increase the efficiency and throughput of process optimization and scale-up.
• Successful implementation can alleviate the bottleneck caused by the accelerated rate of lead compound discovery.

Conclusions:

• Adapting high-throughput screening methodologies is crucial for overcoming manufacturing challenges in drug development.
• Implementing HTS in process chemistry enables cost-effective and scalable production of drug candidates.
• This strategic shift enhances overall productivity in the pharmaceutical pipeline, from discovery to manufacturing.